XRAY dentsplysirona.com: Company Value to Revenue

Official company branding of Dentsply Sirona (XRAY)

The EV/Sales multiple on the precise GURU.Markets chart, where the latest reading is 1055.48, demonstrates confidence in DENTSPLY SIRONA Inc. (XRAY), a global leader in dental equipment with a robust patent portfolio. This price action depends on the demand for high-end aesthetic dental restoration during crises, while the strategy is based on the digitalization of prosthesis design and logistics optimization.

dentsplysirona.com (XRAY): Enterprise Value-to-Revenue Ratio from 11/23/2025 to 11/20/2026

XRAY (Sirona Dental Systems): analytical breakdowns and indicator data

- current quotes and average value forecast:
- company stock capitalization data:
- cash balance and cash flow data:
Fundamental company valuation:DENTSPLY SIRONA Inc., XRAY
Manufactured products of Dentsply

This indicator compares the total enterprise value, including debt and subtracting cash, with annual sales, thereby eliminating the impact of debt load on the valuation. An analysis of DENTSPLY SIRONA Inc. (XRAY) using the EV/Sales multiple reveals how effectively the scaling of the DS Core cloud ecosystem and aligner production translate into market value, confirming the asset's fundamental stability.

Competitor analysis for DENTSPLY SIRONA Inc.

ISRG - EV/Sales Multiple|DHR: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple BD (BDX)|Enterprise Value-to-Revenue Ratio STERIS plc|Company Value to Revenue Ratio WST (West Pharmaceutical Services)|Company Value to Revenue BAX (Baxter Corp)|Masimo - Company Value to Revenue Ratio|Stevanato Group S.p.A. - Company Value to Revenue|Total Company Value-to-Revenue Ratio Teleflex Inc (TFX)|MMSI - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Envista Holdings Corp NVST|ICUI: EV/Sales Multiple|LMAT (LeMaitre Vascular, Inc.) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue ATRC|STAA (STAAR Surgical) - Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio ChromaDex (NAGE)|Company Value to Revenue ZimVie Inc. ZIMV|EV/Sales Multiple ANGO (angiodynamics.com)|EV/Sales Multiple cerus.com CERS|teknova.com - EV/Sales Multiple|Enterprise Value-to-Sales Ratio Monogram Technologies Inc. (MGRM)|Sharps Technology, Inc. (STSS) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Revenue Multiple InfuSystem Inc (INFU)|UTMD (Utah Medical Products Inc.) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple KORU Medical Systems KRMD|Enterprise Value-to-Revenue Ratio Nyxoah SA (NYXH)|Enterprise Value-to-Revenue Coefficient MBOT|EV/Sales Multiple PDEX (Pro-Dex Inc.)|Enterprise Value-to-Revenue Coefficient ZTEK (Zentek Limited)|elutia.com - EV/Sales Multiple|Business Value to Revenue MLSS (milestonescientific.com)|NXGL (NEXGEL Inc.) - Company Value to Revenue|Retractable Technologies - Business Value to Revenue|Enterprise Value-to-Revenue Ratio harvardbioscience.com|Femasys Corp (FEMY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple MHUA|Predictive Oncology Inc. - Company Value to Revenue Ratio|EV/Sales Multiple CJMB (Callan JMB Inc)|EV/Sales Multiple Atrion Corp ATRI|NeuroMetrix Corporation - EV/Sales Multiple